{"name":"Shanghai Pharmaceuticals","slug":"shanghai-pharma","ticker":"2607.HK","exchange":"HKEX","domain":"sphchina.com","description":"Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.","hq":"Shanghai, China","founded":0,"employees":"49608","ceo":"Zhou Jun","sector":"Pharma Distribution & Manufacturing","stockPrice":11.98,"stockChange":0.02,"stockChangePercent":0.17,"marketCap":"$6.5B","metrics":{"revenue":42457566895.74658,"revenueGrowth":6.4,"grossMargin":10.8,"rdSpend":0,"netIncome":856176686.6629632,"cash":6059839444.409221,"dividendYield":3.76,"peRatio":6.7,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-06-01","label":"Lipitor patent cliff ($1.2B at risk)","drug":"Lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Plavix patent cliff ($500M at risk)","drug":"Plavix","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"SPH3127 tablet Dose 1","genericName":"SPH3127 tablet Dose 1","slug":"sph3127-tablet-dose-1","indication":"Other","status":"phase_3"},{"name":"B001","genericName":"B001","slug":"b001","indication":"Other","status":"phase_2"},{"name":"LT3001 Drug:low dose","genericName":"LT3001 Drug:low dose","slug":"lt3001-drug-low-dose","indication":"Other","status":"phase_2"},{"name":"LTS 0.5mg","genericName":"LTS 0.5mg","slug":"lts-0-5mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"SPH3127 tablet Dose 1","genericName":"SPH3127 tablet Dose 1","slug":"sph3127-tablet-dose-1","phase":"phase_3","mechanism":"SPH3127 tablet Dose 1 is a drug with an unknown mechanism of action.","indications":[],"catalyst":""},{"name":"B001","genericName":"B001","slug":"b001","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"LT3001 Drug:low dose","genericName":"LT3001 Drug:low dose","slug":"lt3001-drug-low-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LTS 0.5mg","genericName":"LTS 0.5mg","slug":"lts-0-5mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2023-09-01","type":"earnings","headline":"Shanghai Pharmaceuticals Reports Strong Q3 2023 Earnings","summary":"The company reported a 15% increase in revenue and a 20% increase in net income compared to the same period last year.","drugName":"","sentiment":"positive"},{"date":"2022-06-15","type":"deal","headline":"Shanghai Pharmaceuticals Partners with US-based Biotech Company","summary":"The partnership aims to develop and commercialize a new cancer treatment in China and other emerging markets.","drugName":"","sentiment":"neutral"},{"date":"2021-03-10","type":"regulatory","headline":"Shanghai Pharmaceuticals Receives FDA Approval for New Cardiovascular Treatment","summary":"The approval marks a significant milestone for the company's cardiovascular franchise and expands its presence in the US market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxQV0NmUHlKTmk4cU9Jb2xEWXhVZjR3b3dxcUdOa3pIbnEzZk5GaDBPWDRuRXZva3NPN2o3TGFpS0EzT2x6T2FDZ1VVV0lXOTAzVmdKSDlDZ1p2dnNTdlJTN0tJMWdGcTJrdUlRUlJEZTV0UFRqQlFkX21fMkdKcHhHeWVPYUVBMTRUaXlmQTR5dDNEbzgyM0I4WmJPdzdoSDJfXzJoQUh4TEk5bGNSSS1saHE1S0tNYmd2bmJVdHRpOVVUMk8wYmlvQ1o4YkhCdXBXTUg3dmxqNHFYQzQ?oc=5","date":"2026-03-31","type":"pipeline","source":"The Globe and Mail","summary":"Shanghai Pharmaceuticals Publishes Audited 2025 Annual Results - The Globe and Mail","headline":"Shanghai Pharmaceuticals Publishes Audited 2025 Annual Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxNd0hhM1V3UXA4YldaRWd0WDluOVNOLW1IblpSVjNKSV9YVTJacnZXTEQ5cWVyZTREVUdieFNGWDJEQndoakdha0NkSzVVNXlEZ1hQa1R3MHZENXRHTjlWcXBvWWtwZnMtY0xTNWlzaFBBN3ctWlZUYUdueFdMQkZJNU5nc29HX1R3TjhnU0FlWXREem11VlAwZEY1RG9WRmdTUWgwYWEwaWhNZ2tNTGY5M0NnM1dZVnZKZnJJeXluWkcwbjdlZGNJaU5pemFHV09ISXR1Qy1tQ2FaemI4c3RvYjhIeHE4aUkwNVYyakQ4cWF6eUNTcHlnUDFXU3pGbmZIc3VhQTQyZG01Rmo0?oc=5","date":"2026-03-19","type":"regulatory","source":"The Globe and Mail","summary":"Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend - The Globe and Mail","headline":"Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQSTkyRHNwcVdGSDBhbmJhdjRPNmYtNGc4REdxSVdNaFhEUzNaaG0weXNVb0ZhQTJ1eVRvT3NfWGdQN3lkSFZxYzhpTVFTOE44UFpZQXEtQXVJR0poZ0pUX0p5Rmo3SXlRaWdVLTF3eFo1Q1BVSDBteGVWdGhUSG8wZnNqSXBSZ0ZKQnhiQ1VRR0RpRm0xRVVVVTNvVS1ncFdjTk5WTks1V0VMUDZtUlYtZE5nVmd3YW13ZVZ6LTVxOTh1M1J0ZEpXcV9DNGRhNzU3cHZTeWhjeDh2SW0wX2ptMWZn?oc=5","date":"2024-01-24","type":"pipeline","source":"Hong Kong Science & Technology Parks Corporation ('HKSTP'","summary":"Shanghai Pharmaceuticals Opens “01LABS@Hong Kong” Co-incubator at Science Park - Hong Kong Science & Technology Parks Corporation ('HKSTP'","headline":"Shanghai Pharmaceuticals Opens “01LABS@Hong Kong” Co-incubator at Science Park - Hong Kong Science & Technology Parks Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNUkF2TFhEdEQ4Uzkzb1YwMnZjQmVGVGF4N1c1WGZaZ1FOR1d5UDJJQ29VNVVnbGJfeDNNellBUlB6MnFpOU01SDNqZGhwdlBuaXY2RVFhWXlLV0VIUEx5MnllV3hWOXl6UEZwQUg0YXlHSVNIeXJWcGh0aFhzRHdXdEE0RERsY2Voai1VSlhwUUVXZ1BFTDZQVDNPeEJNMzk2eW1zWA?oc=5","date":"2023-09-04","type":"pipeline","source":"Yicai Global","summary":"Shanghai Pharma Dips After Regulators Put Former Execs Under Investigation - Yicai Global","headline":"Shanghai Pharma Dips After Regulators Put Former Execs Under Investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBzTXVIT08ydjFLaGJHSFRzOTRaMXRjcGpoQWoyMkx1NTJSY3ZobTZpWTJCM29lTk5VN29mbll1T0xmVUZ4d21qeDRLaFpRNmtjNmJzSEJB?oc=5","date":"2018-10-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"China Resources Pharmaceutical Group Limited (3320.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"China Resources Pharmaceutical Group Limited (3320.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1uNFZMOG56eUJGakZDX1FKeEpidU42Vm1kWUQyekRESzNDcEExUzVTX0VKR1NKUkFON3ZzeWtOTGNzc3NheDBFWmxodUNUVS16TDh3NHNR?oc=5","date":"2018-06-03","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) Stock Price, News, Quote & History - Yahoo! Finan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeWRDaVlQa0xzcktiR3N2NkdER0pYLS13Mm45N2d1dFVMRjJVaV9iOFpQd21nRU9xZEw1a3lJRV9fV19haXJiSm9BLUxpcFV1R3Z3WWxqcUtYa1c5d2VPQjgyYTlBeVlBTzhSeDlYTDV0ODcxSFJaZFNKUzVHU3ItZ2hJa3FMTUlPalJwZTVIS0tnUVROV1BRS2VQRkVuZHJIMERHdl82c0VjZF9vSkx4Yk5NTkxyNmsyV3BQZ3hvVQ?oc=5","date":"2018-05-30","type":"pipeline","source":"Zacks Small Cap Research","summary":"DMA.V: What Does the Shanghai Pharma Acquisition Mean to DiaMedica? - Zacks Small Cap Research","headline":"DMA.V: What Does the Shanghai Pharma Acquisition Mean to DiaMedica?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE8xVFY3Wjl4bzJwSW8zeXJUM1B0NnZWdFdfTXY5YnZNYzgzTUYwZVhOOVFDR2pSdF85UzR0Q3ByVkw1Y0lrVDNONnJlclN3WWs4VnhZZVZR?oc=5","date":"2017-06-12","type":"pipeline","source":"Yahoo Finance Singapore","summary":"China Shineway Pharmaceutical Group Limited (2877.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"China Shineway Pharmaceutical Group Limited (2877.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5TQzFsQ1NTcGw1Smc2VTlRRm9OUFhmcHIwSTBERnA3ZFdPRDRDdzZRRkVBWWpmUmxzXzNsdktJV0Q1VmlVSXUyXzd4UVFwOEZQaUpTUC1n?oc=5","date":"2017-06-11","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9wRkowSVBEcXRDU3dnVU5QRDdnV2c2WnhxamZYOG05YkVIZUZnLTMtdmdyZDhfMUdpRjZlWVVDek5jQU9IMEgxRTlkSXc0TWxqX2NsdG5n?oc=5","date":"2017-05-30","type":"pipeline","source":"Yahoo Finance Australia","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) stock price, news, quote and history - Yahoo Finance Australia","headline":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Lipitor","drugSlug":"atorvastatin","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Plavix","drugSlug":"clopidogrel","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":500000000}],"drugCount":4,"phaseCounts":{"phase_3":1,"phase_2":2,"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sino Biopharmaceutical","Hengrui Pharmaceutical","Jiangsu Hengrui Medicine"],"therapeuticFocus":["Cardiovascular","Oncology","Infectious Diseases"],"financials":{"source":"yahoo_finance","revenue":41794463466.86498,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":41794463466.86498},{"period":"2024-12-31","value":40566969978.19284},{"period":"2023-12-31","value":38362750930.80488},{"period":"2022-12-31","value":34189814566.19407}],"grossProfit":4482834610.058168,"grossProfitHistory":[{"period":"2025-12-31","value":4482834610.058168},{"period":"2024-12-31","value":4514550308.259971},{"period":"2023-12-31","value":4617197010.265938},{"period":"2022-12-31","value":4493136155.548874}],"rdSpend":344874734.65352464,"rdSpendHistory":[{"period":"2025-12-31","value":344874734.65352464},{"period":"2024-12-31","value":352895893.09659386},{"period":"2023-12-31","value":324834385.9930601},{"period":"2022-12-31","value":311299417.9875955}],"sgaSpend":1273344725.176691,"operatingIncome":1368167985.3235586,"operatingIncomeHistory":[{"period":"2025-12-31","value":1368167985.3235586},{"period":"2024-12-31","value":1428116423.3528543},{"period":"2023-12-31","value":1409727921.6016173},{"period":"2022-12-31","value":1294159551.3496869}],"netIncome":843695418.0562556,"netIncomeHistory":[{"period":"2025-12-31","value":843695418.0562556},{"period":"2024-12-31","value":670959699.2694685},{"period":"2023-12-31","value":555334447.6335671},{"period":"2022-12-31","value":827865804.5626591}],"eps":1.54,"epsHistory":[{"period":"2025-12-31","value":1.54},{"period":"2024-12-31","value":1.23},{"period":"2023-12-31","value":1.02},{"period":"2022-12-31","value":1.61}],"cash":4822591400.276993,"cashHistory":[{"period":"2025-12-31","value":4822591400.276993},{"period":"2024-12-31","value":5268062333.785074},{"period":"2023-12-31","value":4497753591.915639},{"period":"2022-12-31","value":4038466238.2980776}],"totalAssets":34361877919.46858,"totalLiabilities":21128867646.974525,"totalDebt":7706101998.659893,"equity":11184998222.376423,"operatingCashflow":907017092.227992,"operatingCashflowHistory":[{"period":"2025-12-31","value":907017092.227992},{"period":"2024-12-31","value":858831558.6895999},{"period":"2023-12-31","value":771030637.169915},{"period":"2022-12-31","value":699084966.7332925}],"capex":-342792140.4849791,"capexHistory":[{"period":"2025-12-31","value":-342792140.4849791},{"period":"2024-12-31","value":-353845180.1058886},{"period":"2023-12-31","value":-437813792.141789},{"period":"2022-12-31","value":-395699975.8341081}],"freeCashflow":564224951.7430129,"dividendsPaid":-412661716.1947886,"buybacks":null,"employees":49608,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":676606809.3658395,"ebit":407781329.12206805,"ebitda":407781329.12206805,"period":"2026-03-31","revenue":11092207345.602943,"epsBasic":0.38,"netIncome":208951544.05882227,"rdExpense":69007498.48934358,"epsDiluted":0.38,"grossProfit":1192744886.666403,"operatingIncome":427652576.70596105},{"sga":-714411610.9113983,"ebit":283988820.58364755,"ebitda":283988820.58364755,"period":"2025-12-31","revenue":10096737478.05051,"epsBasic":null,"netIncome":85111877.90957227,"rdExpense":121520697.35300769,"epsDiluted":null,"grossProfit":1178580485.4744854,"operatingIncome":303693948.50037533},{"sga":1372860775.0033708,"ebit":275647254.8535021,"ebitda":275647254.8535021,"period":"2025-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":12739348.215467803,"ebit":753373198.4164594,"ebitda":753373198.4164594,"period":"2025-06-30","revenue":10439090059.878721,"epsBasic":null,"netIncome":460685114.73702836,"rdExpense":68079446.69645864,"epsDiluted":null,"grossProfit":1131356968.758377,"operatingIncome":369935915.53790647},{"sga":602156212.8692509,"ebit":382720423.8474914,"ebitda":382720423.8474914,"period":"2025-03-31","revenue":10429104844.6075,"epsBasic":0.36,"netIncome":196470282.96858504,"rdExpense":73252214.2284921,"epsDiluted":0.36,"grossProfit":1069454016.385651,"operatingIncome":373512611.32512015},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":9671516155.502287,"epsBasic":null,"netIncome":73447750.21664087,"rdExpense":114705231.6867029,"epsDiluted":null,"grossProfit":1098671834.65242,"operatingIncome":295723625.83075494}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":11.98,"previousClose":11.96,"fiftyTwoWeekHigh":13.12,"fiftyTwoWeekLow":10.94,"fiftyTwoWeekRange":"10.94 - 13.12","fiftyDayAverage":11.69,"twoHundredDayAverage":11.96,"beta":0.25,"enterpriseValue":11246796381.843538,"forwardPE":6.6,"priceToBook":0.5,"priceToSales":0.15,"enterpriseToRevenue":0.27,"enterpriseToEbitda":7.02,"pegRatio":0,"ebitda":1602606182.0589976,"ebitdaMargin":3.8,"freeCashflow":-177905482.52654463,"operatingCashflow":1083082471.5925145,"totalDebt":8671151097.863947,"debtToEquity":64.3,"currentRatio":1.34,"returnOnAssets":2.4,"returnOnEquity":8.1,"analystRating":"1.9 - Buy","recommendationKey":"buy","numberOfAnalysts":9,"targetMeanPrice":13.96,"targetHighPrice":15.8,"targetLowPrice":10.63,"dividendRate":0.45,"payoutRatio":0.26,"fiveYearAvgDividendYield":4.23,"exDividendDate":1767052800,"insiderHeldPercent":35,"institutionHeldPercent":13.1,"sharesOutstanding":919072704,"floatShares":1563482422,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":1.8,"epsForward":1.82,"revenuePerShare":77.68,"bookValue":24.03,"officers":[{"age":53,"name":"Mr. Qiuhua  Yang","title":"Executive Chairman"},{"age":53,"name":"Ms. Yadong  Zhou","title":"VP & CFO"},{"age":55,"name":"Mr. Yongzhong  Li","title":"Executive President & Executive Director"},{"age":49,"name":"Mr. Ming  Dong","title":"Executive Director"},{"age":53,"name":"Mr. Yong  Zhao","title":"Employee Representative Director & VP"},{"age":53,"name":"Mr. Tao  Zhong","title":"VP, Board Secretary & Joint Company Secretary"},{"age":37,"name":"Ms. Shuai  Shao","title":"Vice President"},{"age":null,"name":"Ms. Pui Kiu  Wong","title":"Joint Company Secretary"}],"industry":"Medical Distribution","irWebsite":"","website":"https://www.sphchina.com","phone":"86 21 6373 0908"}}